U.S. Semiconductors Stock News

If you’re holding shares of RBC Bearings, or thinking about jumping in, chances are you’re watching those price swings and wondering: is there more gas in the tank, or is it time to tap the brakes? Even with a minor dip of -2.6% in the past week and -3.4% over the past month, the stock is still up an impressive 25.7% year-to-date. Zoom out to a wider lens, and that momentum looks even stronger with returns of 30.6% over a year, 72.8% over three years, and a whopping 193.1% over five years,...

Wondering whether to hold on to ZoomInfo Technologies, make a move, or simply stay on the sidelines? You are not alone. This stock has been catching the eye of investors trying to decide if its latest moves are signs of a fresh start or a warning sign. After a fairly positive climb of 4.3% over the last 30 days, ZoomInfo’s stock took a modest dip this week, closing at $10.67, down 8.1% in the past seven days. For the year, it is up just 2.0%, though the path here has been anything but smooth...

Eagle Materials' (NYSE:EXP) stock up by 9.7% over the past three months. Given that the market rewards strong...

If you are considering what to do with Essex Property Trust stock right now, you are not alone. Many investors are weighing whether the recent dip is a sign of opportunity or cause for caution. After a three-year return of 32.5% and a five-year gain of 43.5%, Essex has clearly delivered for long-term investors. Lately, though, the story has been a little bumpier. The stock closed recently at $261.34, down 1.8% in the last week, 2.5% for the past month, and 6.5% year to date. Even over the...

If you're holding Atkore shares or thinking about jumping in, you're probably asking the big question right now: are these prices offering a good deal, or has the market priced in all the potential? The answer isn't straightforward, but a closer look at Atkore's recent moves makes things interesting. Over the past week, Atkore has climbed 4.9%, adding to a 7.5% gain this past month. These short-term bumps might signal renewed optimism or changing risk perceptions among investors. Step back,...

Deciding what to do with your Tetra Tech shares right now might feel like a tough call, but you are definitely not alone. The stock has given investors a bit of a roller-coaster ride lately, with a slight 0.7% gain over the last week. It is still down 6.2% for the month and off 15.1% year-to-date. The longer view tells a different story, however. Over three years, Tetra Tech is up 36.0% and has delivered a strong 61.6% return over the past five years. That contrast between short-term pressure...

On October 6, 2025, Senseonics Holdings announced preliminary unaudited revenue for the third quarter ended September 30, reporting approximately US$8.1 million, an increase of 91% over the same period in 2024, primarily attributed to roughly 160% new patient growth in the U.S. This upturn in both revenue and new patient adoption highlights more robust market traction, suggesting a potential acceleration in demand for the company’s continuous glucose monitoring systems. We’ll now explore how...

If you're standing at the crossroads of what to do with your Knife River shares or thinking of putting some capital to work, you're not alone. Knife River’s recent performance has grabbed the attention of both cautious investors and opportunists, sparking plenty of debate on whether the current price fairly reflects the company’s long-term prospects. Knife River's stock price has seen a difficult stretch lately. Down 3.9% in the last week, 11.6% in the last month, and a hefty 29.2%...

AC Immune (NasdaqGM:ACIU) just shared peer-reviewed data from its Phase 1b/2a trial of ACI-35.030, an active immunotherapy targeting Tau in early Alzheimer's, developed with Janssen. The findings highlight a rapid and sustained antibody response as well as a clean safety profile. See our latest analysis for AC Immune. With this encouraging clinical update, AC Immune is starting to turn heads, especially as the company’s latest innovation underscores its growing potential in Alzheimer’s...

In September 2025, Bayer’s Consumer Health division announced it had selected Interpublic Group as its exclusive global creative, production, and media agency partner for iconic self-care brands including Aspirin and Claritin. This partnership signals Bayer’s commitment to integrated marketing powered by GenAI for both global consistency and tailored local consumer engagement. We'll review how IPG’s appointment as Bayer’s lead global partner could strengthen its client portfolio and...

Cheche Group Inc.'s ( NASDAQ:CCG ) price-to-sales (or "P/S") ratio of 0.2x may look like a pretty appealing investment...

Key Insights Institutions' substantial holdings in DorianG implies that they have significant influence over the...

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Verizon Communications Inc. ( NYSE:VZ ) stock is about to trade ex-dividend in two days. The ex-dividend date is one...

Despite an already strong run, Hyperfine, Inc. ( NASDAQ:HYPR ) shares have been powering on, with a gain of 30% in the...

The Corcept Therapeutics Incorporated ( NASDAQ:CORT ) share price has done very well over the last month, posting an...

Despite an already strong run, Amprius Technologies, Inc. ( NYSE:AMPX ) shares have been powering on, with a gain of...

Over the past year, many Driven Brands Holdings Inc. ( NASDAQ:DRVN ) insiders sold a significant stake in the company...

As of October 2025, the U.S. stock market is experiencing a notable upswing, with both the Nasdaq and S&P 500 reaching new closing highs despite ongoing government shutdown concerns. This positive momentum in major indices highlights investor optimism, particularly in high-growth sectors like technology, where companies are often characterized by innovative products and robust potential for future expansion.

As the U.S. stock market continues to reach new heights, with the Nasdaq and S&P 500 setting fresh closing records, investors are keenly observing opportunities amidst this bullish trend. In such an environment, identifying stocks priced below their estimated value can be a prudent strategy for those looking to potentially capitalize on market inefficiencies.

As the Nasdaq and S&P 500 reach new closing highs, buoyed by significant tech deals and a resilient market response to the ongoing U.S. government shutdown, investors are increasingly focused on stocks that demonstrate both robust growth potential and strong insider confidence. In this thriving market environment, companies with high insider ownership often signal enduring trust in their long-term prospects, making them compelling considerations for those looking to align with informed...

As the U.S. stock market continues to reach new heights, with the Nasdaq and S&P 500 posting record closing highs, investors are increasingly seeking opportunities that offer both growth potential and reliable income streams. In this vibrant economic landscape, dividend stocks stand out as a compelling choice for those looking to balance risk and reward while capitalizing on consistent returns.

IDT Corporation ( NYSE:IDT ) shareholders that were waiting for something to happen have been dealt a blow with a 25...

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...